Masahide Matsuda

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMedical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
Postoperative Diffusion-Weighted Imaging Hyperintensity Following Combined Photodynamic Diagnosis and Therapy Using 5-Aminolevulinic Acid and Talaporfin Sodium in Malignant Brain Tumors.

|Dec 30, 2025
Radiodynamic Therapy for High-Grade Glioma in Normoxic and Hypoxic Environments for High-Grade Glioma.

Erika Yamada, Eiichi Ishikawa, Tsubasa Miyazaki

|Apr 14, 2025
Significance of 5-ALA-Guided Fluorescence in Resection of Invasive Intracranial Meningiomas: Findings from a Prospective Clinical Study.

Masahide Matsuda, Narushi Sugii, Noriaki Sakamoto

|Nov 29, 2024
Establishment of a novel benign meningioma cell line spontaneously immortalized under hypoxic conditions.

Takaaki Ishikawa, Masahide Matsuda, Hiroshi Ishikawa

|Oct 05, 2021
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial.

Yoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa

|Nov 06, 2020
Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.

Narushi Sugii, Masahide Matsuda, Genki Okumura

Pageof 2

Frequent Collaborators

3 joint publications

Eiichi Ishikawa

1 joint publications

Yoshitaka Narita

1 joint publications

Motoo Nagane

1 joint publications

Noriaki Sakamoto